Wendye Robbins

Wendye Robbins is a highly experienced serial entrepreneur in the life sciences industry, focusing on creating innovative solutions for challenging medical conditions in collaboration with investors.

With a strong educational background, Wendye obtained her MD from The Medical College of Pennsylvania and a BS from the University of California, Berkeley's Haas School of Business. She also completed internships, residencies, and fellowships at reputable institutions like the University of Pennsylvania School of Medicine and The Johns Hopkins University School of Medicine.

Throughout her career, Wendye has held various pivotal roles in prominent organizations. She has served on the Board of Directors and Audit and Pricing Committees at RAPT Therapeutics, was involved with the California Life Sciences Association (CLSA), and acted as President and CEO at Blade Therapeutics. Additionally, Wendye has contributed her expertise to companies like Third Rock Ventures, Labrys Biologics, Limerick BioPharma, NeurogesX, Inc., and more.

Wendye Robbins' professional interests lie in team building, translational medicine, and mentoring, which have been evident in her diverse roles as a clinical associate professor at Stanford University School of Medicine and as an assistant professor at UCSF School of Medicine.

With a remarkable career spanning various leadership positions and educational achievements, Wendye Robbins remains a driving force in the life sciences and entrepreneurial landscape, continuously striving to pioneer new treatments and therapies for unmet medical needs.